Used as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the development of COX-2 inhibitors. Its structure supports selective binding to cyclooxygenase-2 enzymes, reducing inflammation with fewer gastrointestinal side effects. Also employed in the preparation of pyrazole-based pharmaceuticals with analgesic and antipyretic properties. Commonly utilized in medicinal chemistry research for optimizing drug candidates targeting inflammatory conditions.